Latest / Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology
Rituximab Therapy for Resistant Myasthenia Gravis
The paper presents a single-center prospective cohort study from Latvia examining the use of the anti-CD20 monoclonal antibody, rituximab, as a treatment for refractory myasthenia gravis (MG). Conducted on nine patients who had failed conventional treatments, the study evaluated the effects of a single low dose over a six-month period. Results indicated significant clinical improvement, marked by a decrease in the Myasthenia Gravis Composite Score (MGCS), and the treatment successfully achieved a steroid-sparing effect, reducing the median daily corticosteroid dose for the cohort. The authors…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.